An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC) and Department of Molecular Biology has derived a molecular signature from tumour transcriptomics data that quantifies the main sources of heterogeneity in the tumour microenvironment. This innovative signature, which the researchers call iHet, offers deeper insights into patients’ responses …
New multimodal signature could predict immunotherapy success
Share.
